FDA NOVEL DRUG APPROVALS FOR 2016: 22 NEW DRUGS DEVELOPED

Clinical trials are at the heart of all advances in healthcare. The more effective treatments, drugs or combination of pharmaceuticals researchers discover, the bigger the chance of finding a cure becomes. In relation to this, FDA’s Center for Drug Evaluation and Research (CDER) plays a huge role in the medical field and its progress. Each year, CDER reviews and approves a number of novel drugs as well as therapeutic biological and other medical products which are safe and effective enough to prevent, detect or treat diseases. Part of these pharmaceuticals are brand new and haven’t been distributed to the drug market until this moment. Others are either very similar or have already been approved used before. Yet, they continue to compete in the marketplace along with the novel products.

HOW MANY ARE THE NOVEL DRUGS APPROVED RECENTLY?

To compare the Novel Drug Approvals for 2016 with those for 2015, we notice a significant slowdown. In 2015 the Center for Drug Evaluation and Research reviewed and approved 45 drugs and products. In 2016, however, only 22 pharmaceuticals successfully passed the review and approval process. So, let’s have a closer look at the full list of the new drugs and see what they are used for.For more information visit our website.

You can find the online version of this article here: https://crotraining.co.uk/fda-novel-drug-approvals-for-2016-22-new-drugs-developed/